Security key
45828J202
INTENSITY THERAPEUTICS, INC. - COM NEW (INTS)
CUSIP: 45828J202
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 142,226
- Total 13F value
- $836,287
- Share change
- +116,264
- SEC-reported price per share
- $5.88
- Number of holders
- 13
- Value change
- +$683,631
- Number of buys
- 11
Report period
Q1 2026
Institutions
13
Top holders
10
INTS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
INTENSITY THERAPEUTICS, INC. SEC filings
INTENSITY THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45828J202
Recent filing periods:
Ownership snapshot
Top reported holders of INTS - INTENSITY THERAPEUTICS, INC. - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SAPIENT CAPITAL LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 3.9%
13D/G row: SAPIENT CAPITAL LLC
Showing 1-6 of 15 holder rows.
Quick read
SAPIENT CAPITAL LLC leads the comparable SEC ownership view at 3.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SAPIENT CAPITAL LLC's linked filing trail.
Comparable ownership
Top 5
SAPIENT CAPITAL LLC
3.9%
ARMISTICE CAPITAL, LLC
2.6%
VANGUARD GROUP INC
1.3%
Rothschild Wealth LLC
1%
GEODE CAPITAL MANAGEMENT, LLC
0.95%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SAPIENT CAPITAL LLC |
13D/G
13F
Company
|
3.9%
|
$312,575
976,797 shares
|
-$11,287 | 30 Jun 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
2.6%
|
$383,505
1,237,113 shares
|
+$113,015 | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
1.3%
|
$266,125
649,084 shares
|
— | 31 Dec 2025 |
| Rothschild Wealth LLC |
13F
Company
|
1%
|
$203,422
495,910 shares
|
— | 31 Dec 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.95%
|
$188,795
460,248 shares
|
— | 31 Dec 2025 |
| Mesirow Financial Investment Management, Inc. |
13F
Company
|
0.52%
|
$102,960
251,000 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
142,226
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
13
Q1 2026 holders
13
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend